Improved biomarkers for prostate cancer: A definite need

Journal of the National Cancer Institute

Volumn 96, Issue 11, 2004, Pages 813-815

  Carter, H Ballentine ^a   Isaacs, William B ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A; BIOLOGICAL MARKER; FATTY ACID DERIVATIVE; PROSTATE SPECIFIC ANTIGEN; RACEMASE; TUMOR MARKER; 2 METHYLACYL COENZYME A RACEMASE; ALPHA-METHYLACYL-COA RACEMASE; ISOMERASE;

BLOOD EXAMINATION; CANCER CELL; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER TISSUE; DISEASE ASSOCIATION; DISEASE MARKER; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILIAL CANCER; FAT INTAKE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; HUMORAL IMMUNITY; IMMUNOBLOTTING; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN MICROARRAY; SENSITIVITY AND SPECIFICITY; BLOOD; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MALE; MASS SCREENING; METABOLISM; MORTALITY; NOTE; PREDICTION AND FORECASTING; PROSTATE TUMOR; STATISTICS; UPREGULATION;

GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS); MALE; MASS SCREENING; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RACEMASES AND EPIMERASES; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 2942521386     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djh174     Document Type: Editorial

References (15)

1. Lu-Yao G, Stukel TA, Yao SL. Prostate-specific antigen screening in elderly men. J Natl Cancer Inst 2003;95:1792-7.
2. Etzioni R, Penson DF, Legler JM, di Tommaso D, Boer R, Gann PH, et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 2002;94:981-90.
3. Draisma G, Boer R, Otto SJ, van der Cruijsen IW, Damhuis RA, Schroder FH, et al. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 2003;95:868-78.
4. Partin AW, Carter HB, Chan DW, Epstein JI, Oesterling JE, Rock RC, et al. Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. J Urol 1990;143:747-52.
5. Jiang Z, Woda BA, Rock KL, Xu Y, Savas L, Khan A, et al. P504S: a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol 2001;25:1397-404.
6. Rubin MA, Zhou M, Dhanasekaran SM, Varambally S, Barrette TR, Sanda MG, et al. Alpha-methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA 2002;287:1662-70.
7. Luo J, Zha S, Gage WR, Dunn TA, Hicks JL, Bennett CJ, et al. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer. Cancer Res 2002;62:2220-6.
8. Giovannucci E, Rimm EB, Colditz GA, Stampfer MJ, Ascherio A, Chute CC, et al. A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 1993;85:1571-9.
9. Hsieh CL, Oakley-Girvan I, Balise RR, Halpern J, Gallagher RP, Wu AH, et al. A genome screen of families with multiple cases of prostate cancer: evidence of genetic heterogeneity. Am J Hum Genet 2001;69: 148-58.
10. Wiklund F, Gillanders EM, Albertus JA, Bergh A, Damber JE, Emanuelsson M, et al. Genome-wide scan of Swedish families with hereditary prostate cancer: suggestive evidence of linkage at 5q11.2 and 19p13.3. Prostate 2003;57:290-7.
11. Zheng SL, Chang BL, Faith DA, Johnson JR, Isaacs SD, Hawkins GA, et al. Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk. Cancer Res 2002;62:6485-8.
12. Zha S, Ferdinandusse S, Denis S, Wanders RJ, Ewing CM, Luo J, et al. Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer. Cancer Res 2003;63:7365-76.
13. Rogers CG, Yan G, Zha S, Gonzalgo ML, Isaacs WB, Luo J, et al. Prostate cancer detection by urinalysis for alpha methylacyl CoA racemase protein. J Urol, in press.
14. Sreekumar A, Laxman B, Rhodes D, Bhagavathula S, Giacherio D, Ghosh D, et al. Humoral immune response to alpha-methylacyl-CoA racemase and prostate cancer. J Natl Cancer Inst 2004;96:834-43.
15. Etzioni R, Kooperberg C, Pepe M, Smith R, Gann PH. Combining biomarkers to detect disease with application to prostate cancer. Biostatistics 2003;4:523-38.